Biosimilars Market 2025 Growth Trends, Share - Global Analysis and Forecasts

Biosimilars Market to 2025 – Global Analysis and Forecasts by Product (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins, Peptides and Others); and Application (Oncology, Autoimmune Diseases, Chronic Diseases, Blood Disorders, Infectious Diseases, Growth Hormone Deficiency and Others)

Report Code: TIPHE100001246 | No. of Pages: 151 | Category: Biotechnology | Status: Upcoming
A biosimilar is a biological product which is similar to an FDA approved biologic product of another manufacturer. Owing to the complexities associated with development & manufacture of biosimilar products, these are manufactured by companies with highly skillful workforce and deep scientific expertise. The FDA approval process for biosimilar products is rigorous and enables high safety to the end users.

A biosimilar is a biological product which is similar to FDA approved biologic product of the manufacturer. A biosimilar product is a substance which is derived from living cells and used for the treatment of various diseases. In terms of safety and effectiveness, a biosimilar product has no clinically meaningful differences from the reference product. The only minor difference in clinically inactive components is allowable in biosimilar product. It is also known as reference products that are used for the development and manufacturing of biological products such as medicines.

The growth of the global biosimilars market can be attributed to the growing demand of pharmaceutical drug supplements, especially for the high priced patented drugs expected to upsurge the growth of the market. Additionally, increasing incidences of chronic diseases add novel opportunities for the global biosimilars market over the forecast period.

The “Global Biosimilars Market Analysis to 2025” is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global biosimilars market with detailed market segmentation by product, application, end user and geography. The global biosimilars market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

On the basis of product the market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, peptides and others. The recombinant non-glycosylated proteins market is further segmented into insulin, recombinant human growth hormone, granulocyte colony-stimulating factor and interferons. The recombinant glycosylated proteins segment is bifurcated into monoclonal antibodies and erythropoietin. The peptides segment is also classified into calcitonin and glucagon. Based on application the market is segmented into oncology, autoimmune diseases, chronic diseases, blood disorders, infectious diseases, growth hormone deficiency and others.

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global biosimilars based on product and application. It also provides market size and forecast till 2025 for overall biosimilars market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East &Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to dominate the biosimilars market in the global arena due to the increasing incidences of cancer, diabetes and autoimmune diseases in the region. Moreover, the Asia-Pacific region is anticipated to show a significant growth rate over the next five years in the global biosimilars market due to the increasing geriatric population in the region.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key biosimilars manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Teva Pharmaceutical Industries Ltd., Pfizer Inc., Biocon, Samsung BioLogics, Mylan N.V., Amgen Inc., Celltrion, Healthcare Co.,Ltd., Sandoz International GmbH, STADA Arzneimittel AG, Dr. Reddy’s Laboratories Ltd. and others.

1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance

2 Key Takeaways

3 Biosimilars Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Biosimilars Market – By Product
3.2.2 Biosimilars Market – By Application
3.2.3 Biosimilars Market – By Region
3.2.3.1 By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
3.3.2 Europe – PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East and Africa – PEST Analysis
3.3.5 South and Central America – PEST Analysis

4 Biosimilars Market – Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

5 Biosimilars Market - Global Analysis
5.1 Global Biosimilars Market Overview
5.2 Global Biosimilars Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trial Analysis
5.6 Expert Opinions
6 Biosimilars Market Revenue and Forecasts to 2025 – Product (US$ Mn)
6.1 Overview
6.2 Product Market Revenue Forecasts and Analysis (US$ Mn)
6.3 Recombinant Non-Glycosylated Proteins Market
6.3.1 Overview
6.3.2 Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3 Insulin Market
6.3.3.1 Overview
6.3.3.2 Insulin Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4 Recombinant Human Growth Hormone Market
6.3.4.1 Overview
6.3.4.2 Recombinant Human Growth Hormone Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5 Granulocyte Colony-Stimulating Factor Market
6.3.5.1 Overview
6.3.5.2 Granulocyte Colony-Stimulating Factor Market Revenue Forecasts and Analysis (US$ Mn)
6.3.6 Interferons Market
6.3.6.1 Overview
6.3.6.2 Interferons Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Recombinant Glycosylated Proteins Market
6.4.1 Overview
6.4.2 Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis (US$ Mn)
6.4.3 Monoclonal Antibodies Market
6.4.3.1 Overview
6.4.3.2 Monoclonal Antibodies Market Revenue Forecasts and Analysis (US$ Mn)
6.4.4 Erythropoietin Market
6.4.4.1 Overview
6.4.4.2 Interferons Market Revenue Forecasts and Analysis (US$ Mn)
6.5 Peptides Market
6.5.1 Overview
6.5.2 Peptides Market Revenue Forecasts and Analysis (US$ Mn)
6.5.3 Calcitonin Market
6.5.3.1 Overview
6.5.3.2 Calcitonin Market Revenue Forecasts and Analysis (US$ Mn)
6.5.4 Glucagon Market
6.5.4.1 Overview
6.5.4.2 Glucagon Market Revenue Forecasts and Analysis (US$ Mn)
6.6 Other Products Market
6.6.1 Overview
6.6.2 Other Products Market Revenue Forecasts and Analysis (US$ Mn)

7 Biosimilars Market Revenue and Forecasts to 2025 – Application (US$ Mn)
7.1 Overview
7.2 Application Market Revenue Forecasts and Analysis (US$ Mn)
7.3 Oncology Market
7.3.1 Overview
7.3.2 Oncology Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Autoimmune Diseases Market
7.4.1 Overview
7.4.2 Autoimmune Diseases Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Chronic Diseases Market
7.5.1 Overview
7.5.2 Chronic Diseases Market Revenue Forecasts and Analysis (US$ Mn)
7.6 Blood Disorders Market
7.6.1 Overview
7.6.2 Blood Disorders Market Revenue Forecasts and Analysis (US$ Mn)
7.7 Infectious Diseases Market
7.7.1 Overview
7.7.2 Infectious Diseases Market Revenue Forecasts and Analysis (US$ Mn)
7.8 Growth Hormone Deficiency Market
7.8.1 Overview
7.8.2 Growth Hormone Deficiency Market Revenue Forecasts and Analysis (US$ Mn)
7.9 Other Applications Market
7.9.1 Overview
7.9.2 Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
8 North America Biosimilars Market Revenue and Forecasts to 2025 – Country Analysis
8.1 North America Biosimilars Market Overview
8.2 North America Biosimilars Market Revenue Forecasts and Analysis (US$ Mn)
8.3 North America Market Revenue Forecasts and Analysis – By Product (US$ Mn)
8.3.1 North America Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
8.3.2 North America Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
8.3.3 North America Peptides Market Revenue Forecasts and Analysis – By Type (US$ Mn)
8.4 North America Market Revenue Forecasts and Analysis – By Application (US$ Mn)
8.5 North America Market Revenue Forecasts and Analysis – By Country (US$ Mn)
8.6 US Market Overview
8.6.1 US Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
8.6.1.1 US Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
8.6.1.2 US Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
8.6.1.3 US Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
8.6.2 US Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)
8.7 Canada Market Overview
8.7.1 Canada Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
8.7.1.1 Canada Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
8.7.1.2 Canada Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
8.7.1.3 Canada Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
8.7.2 Canada Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)
8.8 Mexico Market Overview
8.8.1 Mexico Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
8.8.1.1 Mexico Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
8.8.1.2 Mexico Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
8.8.1.3 Mexico Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
8.8.2 Mexico Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)
`
9 Europe Biosimilars Market Revenue and Forecasts to 2025 – Country Analysis
9.1 Europe Biosimilars Market Overview
9.2 Europe Biosimilars Market Revenue Forecasts and Analysis (US$ Mn)
9.3 Europe Market Revenue Forecasts and Analysis – By Product (US$ Mn)
9.3.1 Europe Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
9.3.2 Europe Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
9.3.3 Europe Peptides Market Revenue Forecasts and Analysis – By Type (US$ Mn)
9.4 Europe Market Revenue Forecasts and Analysis – By Application (US$ Mn)
9.5 Europe Market Revenue Forecasts and Analysis – By Country (US$ Mn)
9.6 UK Market Overview
9.6.1 UK Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.6.1.1 UK Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.6.1.2 UK Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.6.1.3 UK Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.6.2 UK Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.7 Germany Market Overview
9.7.1 Germany Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.7.1.1 Germany Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.7.1.2 Germany Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.7.1.3 Germany Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.7.2 Germany Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.8 France Market Overview
9.8.1 France Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.8.1.1 France Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.8.1.2 France Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.8.1.3 France Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.8.2 France Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)

10 Asia Pacific Biosimilars Market Revenue and Forecasts to 2025 – Country Analysis
10.1 Asia Pacific Biosimilars Market Overview
10.2 Asia Pacific Biosimilars Market Revenue Forecasts and Analysis (US$ Mn)
10.3 Asia Pacific Market Revenue Forecasts and Analysis – By Product (US$ Mn)
10.3.1 Asia Pacific Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
10.3.2 Asia Pacific Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
10.3.3 Asia Pacific Peptides Market Revenue Forecasts and Analysis – By Type (US$ Mn)
10.4 Asia Pacific Market Revenue Forecasts and Analysis – By Application (US$ Mn)
10.5 Asia Pacific Market Revenue Forecasts and Analysis – By Country (US$ Mn)
10.6 Japan Market Overview
10.6.1 Japan Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.6.1.1 Japan Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.6.1.2 Japan Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.6.1.3 Japan Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.6.2 Japan Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.7 China Market Overview
10.7.1 China Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.7.1.1 China Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.7.1.2 China Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.7.1.3 China Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.7.2 China Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8 India Market Overview
10.8.1 India Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.1.1 India Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.8.1.2 India Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.8.1.3 India Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.8.2 India Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)

11 Middle East and Africa (MEA) Biosimilars Market Revenue and Forecasts to 2025 – Country Analysis
11.1 Middle East & Africa Biosimilars Market Overview
11.2 Middle East & Africa Biosimilars Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Middle East & Africa Market Revenue Forecasts and Analysis – By Product (US$ Mn)
11.3.1 Middle East & Africa Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
11.3.2 Middle East & Africa Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
11.3.3 Middle East & Africa Peptides Market Revenue Forecasts and Analysis – By Type (US$ Mn)
11.4 Middle East & Africa Market Revenue Forecasts and Analysis – By Application (US$ Mn)
11.5 Middle East & Africa Market Revenue Forecasts and Analysis – By Country (US$ Mn)
11.6 South Africa Market Overview
11.6.1 South Africa Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.6.1.1 South Africa Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.6.1.2 South Africa Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.6.1.3 South Africa Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.6.2 South Africa Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.7 Saudi Arabia Market Overview
11.7.1 Saudi Arabia Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.7.1.1 Saudi Arabia Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.7.1.2 Saudi Arabia Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.7.1.3 Saudi Arabia Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.7.2 Saudi Arabia Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8 UAE Market Overview
11.8.1 UAE Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.1.1 UAE Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.8.1.2 UAE Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.8.1.3 UAE Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.8.2 UAE Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)

12 South and Central America Biosimilars Market Revenue and Forecasts to 2025 – Country Analysis
12.1 South and Central America Biosimilars Market Overview
12.2 South and Central America Biosimilars Market Revenue Forecasts and Analysis (US$ Mn)
12.3 South and Central America Market Revenue Forecasts and Analysis – By Product (US$ Mn)
12.3.1 South and Central America Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
12.3.2 South and Central America Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis – By Type (US$ Mn)
12.3.3 South and Central America Peptides Market Revenue Forecasts and Analysis – By Type (US$ Mn)
12.4 South and Central America Market Revenue Forecasts and Analysis – By Application (US$ Mn)
12.5 South and Central America Market Revenue Forecasts and Analysis – By Country (US$ Mn)
12.6 Brazil Market Overview
12.6.1 Brazil Biosimilars Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.6.1.1 Brazil Recombinant Non-Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.6.1.2 Brazil Recombinant Glycosylated Proteins Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.6.1.3 Brazil Peptides Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.6.2 Brazil Biosimilars Market Revenue Forecasts and Analysis-By Application (US$ Mn)

13 Industry Landscape
13.1 Organic Growth Strategies
13.1.1 New Type Launches
13.1.2 Marketing & Promotional Activities
13.2 Inorganic Growth Strategies
13.2.1 Partnerships, Collaborations, and Joint Ventures
13.2.2 Mergers & Acquisitions

14 Biosimilars Market, Key Company Profiles
14.1 Teva Pharmaceutical Industries Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 Product Pipeline
14.1.6 SWOT Analysis
14.1.7 Key Developments
14.2 Pfizer Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Overview
14.2.4 Product Portfolio
14.2.5 Product Pipeline
14.2.6 SWOT Analysis
14.2.7 Key Developments
14.3 Biocon
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 Product Pipeline
14.3.6 SWOT Analysis
14.3.7 Key Developments
14.4 Samsung BioLogics
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 Product Pipeline
14.4.6 SWOT Analysis
14.4.7 Key Developments
14.5 Mylan N.V.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 Product Portfolio
14.5.5 Product Pipeline
14.5.6 SWOT Analysis
14.5.7 Key Developments
14.6 Amgen Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 Product Pipeline
14.6.6 SWOT Analysis
14.6.7 Key Developments
14.7 Celltrion Healthcare Co.,Ltd.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 Product Pipeline
14.7.6 SWOT Analysis
14.7.7 Key Developments
14.8 Sandoz International GmbH
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 Product Pipeline
14.8.6 SWOT Analysis
14.8.7 Key Developments
14.9 STADA Arzneimittel AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product Portfolio
14.9.5 Product Pipeline
14.9.6 SWOT Analysis
14.9.7 Key Developments
14.10 Dr. Reddy’s Laboratories Ltd.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product Portfolio
14.10.5 Product Pipeline
14.10.6 SWOT Analysis
14.10.7 Key Developments
15 Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
15.3 Research Methodology

Healthcare
The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. Pfizer Inc.
3. Biocon
4. Samsung BioLogics
5. Mylan N.V.
6. Amgen Inc.
7. Celltrion Healthcare Co.,Ltd.
8. Sandoz International GmbH
9. STADA Arzneimittel AG
10. Dr. Reddy’s Laboratories Ltd.

Select License Type
USD $4550
USD $9100
USD $13650

Free

20%

customization on Pre-Booking
Pre Book